Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

AIMS: To assess quantitatively the safety and pharmacology of paclitaxel in patients with moderate to severe hepatic impairment. METHODS: Solid tumour patients were enrolled into five liver function cohorts as defined by liver transaminase and total bilirubin concentrations. Paclitaxel was administe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Joerger, M, Huitema, A D R, Huizing, M T, Willemse, P H B, de Graeff, A, Rosing, H, Schellens, J H M, Beijnen, J H, Vermorken, J B
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 2007
Pynciau:
Pharmacokinetics and Pharmacodynamics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2203269/
https://ncbi.nlm.nih.gov/pubmed/17935602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02956.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg